Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 21.12% is 309% above its 5-year average of 5.17%, near the high end of its 5-year range (-37.32%–32.35%).
235.40% above its 12-month average of 6.30%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -15.58%.
EBITDA MARGIN
21.12%
EBITDA MARGIN AVG TTM
6.30%
EBITDA MARGIN AVG 3Y
5.62%
EBITDA MARGIN AVG 5Y
5.17%
EBITDA MARGIN AVG 10Y
-3.29%
EBITDA MARGIN AVG 15Y
-21.43%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+235.40%
CURRENT VS 3Y AVG
+275.73%
CURRENT VS 5Y AVG
+308.68%
CURRENT VS 10Y AVG
+741.16%
CURRENT VS 15Y AVG
+198.55%
CURRENT VS 20Y AVG
N/A
Market Cap
$1.14B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
EBITDA Margin
-0.59%
TTM Avg
3.42%
3Y Avg
-15.99%
5Y Avg
-18.77%
Market Cap
$1.12B
EBITDA Margin
28.28%
TTM Avg
32.08%
3Y Avg
32.10%
5Y Avg
26.80%
Market Cap
$1.16B
EBITDA Margin
21.67%
TTM Avg
19.38%
3Y Avg
14.20%
5Y Avg
2.75%
Market Cap
$1.11B
EBITDA Margin
34.04%
TTM Avg
32.58%
3Y Avg
31.87%
5Y Avg
26.02%
Market Cap
$1.20B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.21B
EBITDA Margin
-2.25%
TTM Avg
-29.69%
3Y Avg
-65.15%
5Y Avg
-190.58%
Market Cap
$1.22B
EBITDA Margin
8.83%
TTM Avg
3.81%
3Y Avg
0.53%
5Y Avg
2.86%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harrow Health, Inc. (HROW) | $1.14B | 21.12% | 6.30% | 5.62% | 5.17% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.14B | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -0.59% | 3.42% | -15.99% | -18.77% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 28.28% | 32.08% | 32.10% | 26.80% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 21.67% | 19.38% | 14.20% | 2.75% |
| IRadimed Corporation (IRMD)vs › | $1.11B | 34.04% | 32.58% | 31.87% | 26.02% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.21B | -2.25% | -29.69% | -65.15% | -190.58% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 8.83% | 3.81% | 0.53% | 2.86% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 3.96% | -13.21% | -146.19% | -104.68% |
Gross Margin
73.3%
EBITDA Margin
21.1%
Operating Margin
14.2%
Net Margin
-13.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -15.58% |
| 2026-03-31 | -37.32% |
| 2025-12-31 | 32.35% |
| 2025-09-30 | 26.96% |
| 2025-06-30 | 25.07% |
| 2025-03-31 | -14.00% |
| 2024-12-31 | 25.88% |
| 2024-09-30 | 8.68% |
| 2024-06-30 | 8.95% |
| 2024-03-31 | -11.79% |
| 2023-12-31 | -5.82% |
| 2023-09-30 | 13.48% |
| 2023-06-30 | 16.20% |
| 2023-03-31 | 13.95% |
| 2022-12-31 | -5.29% |
| 2022-09-30 | 2.08% |
| 2022-06-30 | 10.59% |
| 2022-03-31 | 13.02% |
| 2021-12-31 | -6.63% |
| 2021-09-30 | -17.47% |
| 2021-06-30 | 25.20% |
| 2021-03-31 | 23.11% |
| 2020-12-31 | 22.71% |
| 2020-09-30 | 16.04% |
| 2020-06-30 | -33.52% |
| 2020-03-31 | -1.14% |
| 2019-12-31 | 12.15% |
| 2019-09-30 | -29.96% |
| 2019-06-30 | -0.64% |
| 2019-03-31 | -0.85% |
| 2018-12-31 | -15.10% |
| 2018-09-30 | -1.56% |
| 2018-06-30 | -1.60% |
| 2018-03-31 | -14.91% |
| 2017-12-31 | -23.16% |
| 2017-09-30 | -35.34% |
| 2017-06-30 | -38.09% |
| 2017-03-31 | -62.26% |
| 2016-12-31 | -52.87% |
| 2016-09-30 | -86.09% |
| 2016-06-30 | -74.34% |
| 2016-03-31 | -81.72% |
| 2015-12-31 | -129.46% |
| 2015-09-30 | -125.12% |
| 2015-06-30 | -169.24% |
| 2015-03-31 | -191.36% |
| 2014-12-31 | -493.61% |
| 2014-09-30 | -552.15% |
| 2014-06-30 | -386.06% |
| 2014-03-31 | -116645.80% |
| 2013-12-31 | -75650.24% |
| 2013-09-30 | -83543.68% |
| 2013-06-30 | -89193.04% |
| 2013-03-31 | -58866.00% |
| 2012-03-31 | -351.60% |
